Insider Buying: Fusion Antibodies plc (LON:FAB) Insider Purchases £3,349.12 in Stock

Fusion Antibodies plc (LON:FAB) insider Adrian Kinkaid bought 83,728 shares of the stock in a transaction that occurred on Wednesday, October 16th. The shares were purchased at an average price of GBX 4 ($0.05) per share, with a total value of £3,349.12 ($4,373.36).

Adrian Kinkaid also recently made the following trade(s):

• On Wednesday, September 4th, Adrian Kinkaid purchased 120,000 shares of Fusion Antibodies stock. The shares were acquired at an average cost of GBX 3 ($0.04) per share, with a total value of £3,600 ($4,700.97).

Fusion Antibodies Trading Down 2.3 %

FAB opened at GBX 4.20 ($0.05) on Friday. The business’s 50-day simple moving average is GBX 3.69 and its 200-day simple moving average is GBX 3.53. The company has a market cap of £4.01 million, a P/E ratio of -105.00 and a beta of 0.49. Fusion Antibodies plc has a one year low of GBX 2.80 ($0.04) and a one year high of GBX 9.50 ($0.12). The company has a debt-to-equity ratio of 2.40, a quick ratio of 2.36 and a current ratio of 3.87.

Fusion Antibodies Company Profile

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services.